SCHEMBL5125563

SCHEMBL5125563

NC(=O)c1ccc(Oc2ccc(CC(N)C(=O)N3CCNCC3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 7/20 0.45
PARP15 Q460N3 3/20 0.45
ALDH1A1 P00352 1/20 0.45
KMT2A Q03164 1/20 0.45
PARP14 Q460N5 1/20 0.45
PARP16 Q8N5Y8 1/20 0.45
PARP11 Q9NR21 1/20 0.45
PARP4 Q9UKK3 1/20 0.45
HRH2 P25021 3/20 0.44
HRH1 P35367 3/20 0.44
DPP4 P27487 3/20 0.43
FAP Q12884 1/20 0.41
DPP8 Q6V1X1 1/20 0.41
DPP9 Q86TI2 1/20 0.41
DPP7 Q9UHL4 1/20 0.41
PARP2 Q9UGN5 1/20 0.41
HDAC8 Q9BY41 3/20 0.41
OPRD1 P41143 1/20 0.41
AKT1 P31749 1/20 0.40
AKT2 P31751 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4921918 0.86 FFAR1 (0.40) HRH2HRH1DPP4FAPDPP8
SCHEMBL5129878 0.86 TSHR (0.45) PARP10PARP15ALDH1A1KMT2APARP14
SCHEMBL5130653 0.86 HRH2 (0.48) PARP10PARP15ALDH1A1KMT2APARP14
SCHEMBL4925531 0.85 FFAR1 (0.50) HRH2HRH1DPP4FAPDPP8
SCHEMBL4598222 0.80 HDAC8 (0.49) HRH2HRH1DPP4HDAC8
SCHEMBL5746194 0.79 HDAC8 (0.62) HRH2HRH1DPP4HDAC8OPRD1
SCHEMBL5746200 0.79 HDAC8 (0.62) HRH2HRH1DPP4HDAC8OPRD1
SCHEMBL3140448 0.78 DPP4 (0.60) HRH2HRH1DPP4FAPDPP8
SCHEMBL7566120 0.78 HDAC8 (0.64) DPP4FAPDPP8DPP9DPP7
SCHEMBL7567649 0.78 HDAC8 (0.64) DPP4FAPDPP8DPP9DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200521-A1 Novel hydroxamic acid containing amino acid derivatives BEXEL PHARMACEUTICALS. INC. 2008-08-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200521-A1 Novel hydroxamic acid containing amino acid derivatives HGFAC, HCAR2, BCAT1 PARP10 4008/4885PARP15 3465/4885ALDH1A1 4228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.